vs
Prenetics Global Ltd（PRE）与沃特世（WAT）财务数据对比。点击上方公司名可切换其他公司
沃特世的季度营收约是Prenetics Global Ltd的217.1倍（$932.4M vs $4.3M）
Prenetics是一家总部位于中国香港的健康科学企业，业务辐射美国地区，专注于癌症等疾病的早期筛查、预防与干预诊疗，致力于帮助人们更早发现健康风险，助力提升相关疾病的治疗效果，推动肿瘤等重疾的早防早治，守护公众健康。
沃特世是总部位于美国马萨诸塞州米尔福德的企业，面向生命科学、材料、食品等行业，提供色谱、质谱、实验室信息学、流变测量领域所用的分析仪器及配套软件，为各领域的检测、研发等工作提供可靠技术支持。
PRE vs WAT — 直观对比
营收规模更大
WAT
是对方的217.1倍
$4.3M
损益表 — Q3 2023 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $4.3M | $932.4M |
| 净利润 | — | $225.2M |
| 毛利率 | 44.9% | 61.1% |
| 营业利润率 | -396.2% | 29.0% |
| 净利率 | — | 24.2% |
| 营收同比 | — | 6.8% |
| 净利润同比 | — | -2.7% |
| 每股收益（稀释后） | — | $3.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PREWAT
| Q4 25 | — | $932.4M | ||
| Q3 25 | — | $799.9M | ||
| Q2 25 | — | $771.3M | ||
| Q1 25 | — | $661.7M | ||
| Q4 24 | — | $872.7M | ||
| Q3 24 | — | $740.3M | ||
| Q2 24 | — | $708.5M | ||
| Q1 24 | — | $636.8M |
净利润PREWAT
| Q4 25 | — | $225.2M | ||
| Q3 25 | — | $148.9M | ||
| Q2 25 | — | $147.1M | ||
| Q1 25 | — | $121.4M | ||
| Q4 24 | — | $231.4M | ||
| Q3 24 | — | $161.5M | ||
| Q2 24 | — | $142.7M | ||
| Q1 24 | — | $102.2M |
毛利率PREWAT
| Q4 25 | — | 61.1% | ||
| Q3 25 | — | 59.0% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 58.2% | ||
| Q4 24 | — | 60.1% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.3% | ||
| Q1 24 | — | 58.9% |
营业利润率PREWAT
| Q4 25 | — | 29.0% | ||
| Q3 25 | — | 24.0% | ||
| Q2 25 | — | 24.4% | ||
| Q1 25 | — | 22.9% | ||
| Q4 24 | — | 33.5% | ||
| Q3 24 | — | 28.5% | ||
| Q2 24 | — | 26.7% | ||
| Q1 24 | — | 21.0% |
净利率PREWAT
| Q4 25 | — | 24.2% | ||
| Q3 25 | — | 18.6% | ||
| Q2 25 | — | 19.1% | ||
| Q1 25 | — | 18.3% | ||
| Q4 24 | — | 26.5% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | 20.1% | ||
| Q1 24 | — | 16.0% |
每股收益（稀释后）PREWAT
| Q4 25 | — | $3.76 | ||
| Q3 25 | — | $2.50 | ||
| Q2 25 | — | $2.47 | ||
| Q1 25 | — | $2.03 | ||
| Q4 24 | — | $3.88 | ||
| Q3 24 | — | $2.71 | ||
| Q2 24 | — | $2.40 | ||
| Q1 24 | — | $1.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $587.8M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | — | $2.6B |
| 总资产 | — | $5.1B |
| 负债/权益比越低杠杆越低 | — | 0.55× |
8季度趋势，按日历期对齐
现金及短期投资PREWAT
| Q4 25 | — | $587.8M | ||
| Q3 25 | — | $459.1M | ||
| Q2 25 | — | $367.2M | ||
| Q1 25 | — | $382.9M | ||
| Q4 24 | — | $325.4M | ||
| Q3 24 | — | $331.5M | ||
| Q2 24 | — | $327.4M | ||
| Q1 24 | — | $338.2M |
总债务PREWAT
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PREWAT
| Q4 25 | — | $2.6B | ||
| Q3 25 | — | $2.3B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.3B |
总资产PREWAT
| Q4 25 | — | $5.1B | ||
| Q3 25 | — | $4.9B | ||
| Q2 25 | — | $4.7B | ||
| Q1 25 | — | $4.6B | ||
| Q4 24 | — | $4.6B | ||
| Q3 24 | — | $4.5B | ||
| Q2 24 | — | $4.4B | ||
| Q1 24 | — | $4.5B |
负债/权益比PREWAT
| Q4 25 | — | 0.55× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.89× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $164.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.73× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PREWAT
| Q4 25 | — | $164.6M | ||
| Q3 25 | — | $187.3M | ||
| Q2 25 | — | $41.1M | ||
| Q1 25 | — | $259.6M | ||
| Q4 24 | — | $240.1M | ||
| Q3 24 | — | $204.6M | ||
| Q2 24 | — | $54.5M | ||
| Q1 24 | — | $262.9M |
现金转化率PREWAT
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 0.28× | ||
| Q1 25 | — | 2.14× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 2.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
